Neurotoxic effects of kainic acid on developing chick retina. 1988

R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
Department of Anatomy, Monash University, Clayton, Vic., Australia.

The neurotoxic effects of kainic acid (KA) on developing neurons in the chick retina was investigated in an in vitro preparation. Eyecups from chick embroyos at 6 (E-6), 8, 10, 12, 14, 16, and 20 days of incubation and from chicks on day 1 posthatch (D-1) were exposed to different doses of KA for 30 min and then processed for light microscopy. Neurotoxic damage was evaluated by the presence of swollen cell bodies, containing pale cytoplasm and pyknotic nuclei. At E-8, amacrine cells first became sensitive to KA and displayed neurotoxic damage at a threshold concentration of 20 microM. Their sensitivity to KA increased over the following 4 days, so that by E-12 they attained a threshold sensitivity of 5.0 microM KA. At E-14, one third of the retinae showed amacrine cell damage at 0.5-2.0 microM KA, less than the threshold dose of 5.0 microM KA required at D-1. Bipolar cells first become sensitive to KA at E-12, at a threshold concentration of 5.0 microM. The threshold concentration decreased over the following 10 days: 2.0 microM at E-16, 1.0 microM at E-20, and 0.5 microM at D-1. At E-8 and E-10, horizontal cells were susceptible to a relatively high concentration of 80 microM KA. The sensitivity to KA is evident prior to the formation of photoreceptor input. These results indicate that amacrine and horizontal cells are susceptible to KA at an earlier age than bipolar cells. Both amacrine and bipolar cells exhibit an age-dependent relationship with the threshold concentration of KA required to cause neurotoxicity; in general, the older the embryo, the lower the dose of KA. However, the increased susceptibility of amacrine cells at E-14 suggests a transient hypersensitivity to KA during this period which may reflect an overproduction of the receptor-ionic channel complex necessary for KA to exert its effect.

UI MeSH Term Description Entries
D007608 Kainic Acid (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Digenic Acid,Kainate,Acid, Digenic,Acid, Kainic
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
May 1986, Brain research,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
December 1982, Neuroscience letters,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
February 1977, Investigative ophthalmology & visual science,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
December 1986, The Journal of comparative neurology,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
July 1983, Journal of neurochemistry,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
March 1982, Critical reviews in toxicology,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
January 1982, Neurochemistry international,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
January 1984, Japanese journal of ophthalmology,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
January 1979, Life sciences,
R De Nardis, and J Sattayasai, and J Zappia, and D Ehrlich
October 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!